Clinical Trial: Evaluation of Spasticity, Neuropathic Pain, and Gait Analysis in Stroke Patients Receiving Tolperison Therapy After Botulinum Toxin Injection

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07482618) titled 'Evaluation of Spasticity, Neuropathic Pain, and Gait Analysis in Stroke Patients Receiving Tolperison Therapy After Botulinum Toxin Injection' on Feb. 04.

Brief Summary: Tolperison is an antispastic agent used in the treatment of spasticity. Studies on tolperison are limited, and the literature on its effectiveness against spasticity and neuropathic pain is also limited.

Study Start Date: Aug. 13, 2025

Study Type: OBSERVATIONAL

Condition: Spastic Hemiplegia

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Ayse Guc

Information provided by (Responsible Party): Ayse Guc, Kayseri City Hospital

Published by HT Digital Content ...